logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.

    Article - En anglais

    Background and objectives 

    The infectiousness and clinical relevance of the newly discovered blood-borne Flaviviridae-like agent, termed hepatitis G virus (HGV), are not well understood.

    Materials and methods 

    Twenty-three transfusion recipients of two HGV-affected long-term blood donors were studied for HGV genome and antibodies to the putative envelope 2 glycoprotein (anti-E2) of HGV.

    Nine recipients had nonhematological disorders and 14 suffered from severe hematological diseases and 7 of them received allogeneic bone marrow or blood stem cell transplantation.

    The molecular epidemiology of the observed HGV infection was studied by direct sequencing of parts of the 5'-noncoding region, NS3, and NS5 region of HGV in the 2 long-term donors and in their 6 recipients who became HGV RNA positive.

    Additionally, 549 individuals - homologous (n=254) and autologous blood donors (n=202), and medical staff (n=89) - were investigated for the presence of HGV RNA.

    Results 

    HGV RNA in serum was found in 15 of the 23 (65%) transfusion recipients with known exposure of HGV-contaminated blood.

    Seven of the remaining 8 recipients showed only an anti-E2 response, indicating previous HGV infection with spontaneous clearance of the virus.

    In one recipient neither HGV RNA nor anti-E2 could be detected.

    Molecular evidence for HGV transmission by the 2 donors was found in 3 of the 6 recipients studied. (...)

    Mots-clés Pascal : Donneur sang, Epidémiologie moléculaire, Allemagne, Europe, Anémie aplasique, Hémopathie maligne, Transfusion, Sang, Contamination, Traitement, Complication, Homme, Hémopathie, Hépatite virale G

    Mots-clés Pascal anglais : Blood donor, Molecular epidemiology, Germany, Europe, Aplastic anemia, Malignant hemopathy, Transfusion, Blood, Contamination, Treatment, Complication, Human, Hemopathy, Viral hepatitis G

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0229275

    Code Inist : 002B27D01. Création : 11/09/1998.